CA2007752A1 - Gels oraux elastiques et extrudables et distributeurs de doses les contenant, methode de fabrication et methode d'utilisation - Google Patents

Gels oraux elastiques et extrudables et distributeurs de doses les contenant, methode de fabrication et methode d'utilisation

Info

Publication number
CA2007752A1
CA2007752A1 CA2007752A CA2007752A CA2007752A1 CA 2007752 A1 CA2007752 A1 CA 2007752A1 CA 2007752 A CA2007752 A CA 2007752A CA 2007752 A CA2007752 A CA 2007752A CA 2007752 A1 CA2007752 A1 CA 2007752A1
Authority
CA
Canada
Prior art keywords
making
metered dose
oral pharmaceutical
gel compositions
pharmaceutical gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2007752A
Other languages
English (en)
Other versions
CA2007752C (fr
Inventor
William George Gorman
Elio Paul Mariani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2007752A1 publication Critical patent/CA2007752A1/fr
Application granted granted Critical
Publication of CA2007752C publication Critical patent/CA2007752C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
CA002007752A 1989-01-17 1990-01-15 Gels oraux elastiques et extrudables et distributeurs de doses les contenant, methode de fabrication et methode d'utilisation Expired - Lifetime CA2007752C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29772089A 1989-01-17 1989-01-17
US07/297,720 1989-01-17
US07/441,849 US5288479A (en) 1989-01-17 1989-11-27 Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US07/441,849 1989-11-27

Publications (2)

Publication Number Publication Date
CA2007752A1 true CA2007752A1 (fr) 1990-07-17
CA2007752C CA2007752C (fr) 1999-09-07

Family

ID=26970285

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002007752A Expired - Lifetime CA2007752C (fr) 1989-01-17 1990-01-15 Gels oraux elastiques et extrudables et distributeurs de doses les contenant, methode de fabrication et methode d'utilisation

Country Status (12)

Country Link
US (1) US5288479A (fr)
EP (1) EP0379147B1 (fr)
JP (1) JP2879917B2 (fr)
KR (1) KR0149494B1 (fr)
AU (1) AU622259B2 (fr)
CA (1) CA2007752C (fr)
DE (1) DE69012842T2 (fr)
DK (1) DK0379147T3 (fr)
FI (1) FI102591B1 (fr)
IE (1) IE64163B1 (fr)
NO (1) NO180282C (fr)
NZ (1) NZ232025A (fr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0421825A1 (fr) * 1989-08-11 1991-04-10 Kadem Farmaseutiese Produktie B.K. Solutions à base de paracétamol
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
JP2807346B2 (ja) * 1991-12-24 1998-10-08 山之内製薬株式会社 口腔内崩壊製剤及びその製造法
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
US5881926A (en) * 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
FR2720944B1 (fr) * 1994-06-09 1996-09-06 Sanofi Sa Composition thérapeutique ou diététique sous forme de gel médicamenteux pour l'administration à des animaux de compagnie.
GB2291348B (en) * 1994-07-18 1999-01-20 Johnson & Johnson Medical Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol
CA2172807C (fr) * 1994-08-01 1999-10-12 Keith S. Lienhop Systeme d'administration de produit pharmaceutique liquide a masquage de gout
US5563177A (en) * 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
WO1998020860A2 (fr) * 1996-11-15 1998-05-22 Fmc Corporation Vecteur d'apport hydrocolloidal
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
ES2258072T3 (es) * 2000-01-19 2006-08-16 Mannkind Corporation Preparacion de liberacion en varias etapas para la administracion de medicamentos.
US6924273B2 (en) * 2000-10-03 2005-08-02 Scott W. Pierce Chondroprotective/restorative compositions and methods of use thereof
TWI320713B (fr) 2001-06-01 2010-02-21 Neochemir Inc
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
CA2764642A1 (fr) * 2001-10-22 2003-05-01 Taro Pharmaceutical Industries Ltd. Dissimulation du gout de formulation resistante a l'ecoulement
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
JP4278932B2 (ja) * 2002-07-31 2009-06-17 伊那食品工業株式会社 ゲル素材溶液
WO2004035022A2 (fr) * 2002-10-15 2004-04-29 Microtherapeutics, Inc. Matieres prepolymeres pour l'administration a un site specifique du corps
CL2003002653A1 (es) * 2002-12-18 2005-04-22 Wyeth Corp Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2006528690A (ja) * 2003-05-07 2006-12-21 ディーエムアイ バイオサイエンシズ インコーポレイテッド 口腔ケア方法および製品
US20050192355A1 (en) * 2004-02-17 2005-09-01 Wyeth Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
JP2006028028A (ja) * 2004-07-12 2006-02-02 Teikoku Medix Kk 経口医薬組成物
WO2006083761A2 (fr) 2005-02-03 2006-08-10 Alza Corporation Solutions de solvant/polymere utilisees comme vehicules de suspension
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
EP1714644B1 (fr) * 2005-04-19 2012-08-08 Innovet Italia S.r.l. Composition pharmaceutique pour le traitement des ulcères chroniques
GB2430364A (en) * 2005-09-22 2007-03-28 Carl Ernest Alexander Soft agar bolus for oral drug delivery
WO2007117605A2 (fr) * 2006-04-06 2007-10-18 Taro Pharmaceuticals North America, Inc. Nouvelles formulations resistantes aux renversements comprenant des polymeres hydrocolloidaux
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
EP2359808B1 (fr) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Système de libération osmotique avec ensemble de piston
WO2008133908A2 (fr) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Formulations en suspension de peptides insulinotropes et leurs utilisations
CA2691531C (fr) 2007-06-22 2016-11-01 Board Of Regents,The University Of Texas System Formation de particules de peptide ou de proteine submicroniques stables par congelation de film mince
ITMI20080114A1 (it) * 2008-01-25 2009-07-26 Gian Battista Ceresa Formulazioni topiche in forma di gel acquosi per il trattamento di dermatite atopica o come veicoli per la somministrazione transdermica di farmaci
CA2726861C (fr) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Dispositifs, formulations et methodes d'administration de plusieurs agents benefiques
EP2376522A4 (fr) 2008-11-16 2013-12-25 Univ Texas Suspensions hautement concentrées de faible viscosité
US8658628B2 (en) * 2009-06-18 2014-02-25 Karan Y. Baucom Hormone delivery system and method
US9795617B2 (en) 2009-06-18 2017-10-24 Baucom Institute for Longevity and Life Enhancement, Inc. Hormone delivery system and method
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
EP2827839B1 (fr) 2012-03-20 2019-02-27 Particle Dynamics International, LLC Forme de dosage à base d'agent gélifiant
NZ709958A (en) * 2013-02-28 2018-03-23 Pfizer Enhanced stability of novel liquid compositions
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
RU2730996C2 (ru) 2015-06-03 2020-08-26 Интарсия Терапьютикс, Инк. Системы установки и извлечения имплантата
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
JP7286542B2 (ja) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
CN110279695B (zh) * 2019-08-07 2022-04-08 北京博智绿洲医药科技有限公司 一种治疗流涕、鼻塞等感冒症状的药物组合物及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (fr) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Composition pharmaceutique contenant de l'interféron stabilisé
EP0084638B1 (fr) * 1982-01-19 1987-12-23 Gap Gesellschaft Für Auswertungen Und Patente Ag Distributeur pour produits pâteux
US4511608A (en) 1982-12-07 1985-04-16 Ferraro Charlotte L Artificial nail mounting, reinforcement, and method
US4569838A (en) * 1983-12-23 1986-02-11 Colgate-Palmolive Company Dentifrice
US4565692A (en) * 1983-12-23 1986-01-21 Colgate-Palmolive Company Extrudable dentifrice
EP0169893A4 (fr) * 1984-01-31 1987-01-22 Scm Corp Composition de matrice d'encapsulage et produit encapsule la contenant.
KR850700213A (ko) * 1984-02-08 1985-12-26 제이.데스몬드 다비스 아세트 아미노펜 젤라틴 캡슐
US4639367A (en) * 1985-03-18 1987-01-27 Product Resources International, Inc. Aerosol foam
US4685593A (en) 1985-05-08 1987-08-11 Isaias Loukos Feeder for highly abrasive materials
US4702905A (en) * 1985-08-30 1987-10-27 Colgate-Palmolive Company Packaged dental cream
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4685594A (en) * 1986-07-03 1987-08-11 Manuel Czech Dispenser for paste-like products

Also Published As

Publication number Publication date
JP2879917B2 (ja) 1999-04-05
AU622259B2 (en) 1992-04-02
US5288479A (en) 1994-02-22
FI900099L (fi) 1990-07-18
NO900227L (no) 1990-07-18
AU4786090A (en) 1990-07-26
NO180282B (no) 1996-12-16
NO900227D0 (no) 1990-01-16
EP0379147A2 (fr) 1990-07-25
FI102591B (fi) 1999-01-15
KR0149494B1 (ko) 1998-10-15
DE69012842T2 (de) 1995-04-20
CA2007752C (fr) 1999-09-07
IE900171L (en) 1990-07-17
IE64163B1 (en) 1995-07-12
DE69012842D1 (de) 1994-11-03
NO180282C (no) 1997-03-26
EP0379147A3 (fr) 1991-04-03
DK0379147T3 (da) 1994-12-12
KR900011452A (ko) 1990-08-01
EP0379147B1 (fr) 1994-09-28
FI900099A0 (fi) 1990-01-09
JPH02247116A (ja) 1990-10-02
FI102591B1 (fi) 1999-01-15
NZ232025A (en) 1991-07-26

Similar Documents

Publication Publication Date Title
CA2007752A1 (fr) Gels oraux elastiques et extrudables et distributeurs de doses les contenant, methode de fabrication et methode d'utilisation
CA2068324A1 (fr) Compositions peptidiques renfermant un metal et methodes de stimulation de la croissance des cheveux
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
IT1217783B (it) Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative
ES8506186A1 (es) Un preparado adhesivo con forma de hoja
MX9801111A (es) Tableta moldeada masticable que contiene sustancias medicinalmente activas.
CA2419993A1 (fr) Preparation de compositions pharmaceutiques a utiliser avec des formulations gelatineuses molles
IE891414L (en) Pharmaceutical compositions
IE800406L (en) Pharmaceutical composition
CA2202397A1 (fr) Compositions comprenant de l'acide dichloroacetique tamponne au carbonate/bicarbonate et procedes de traitement de troubles metaboliques et cardiovasculaires
IE781032L (en) Pharmaceutical compositions
CA2189436A1 (fr) Composition d'hygiene buccale
DE2966411D1 (en) Imidazolylvinylethers, their preparation and application as active agent in pharmaceutical and biocidal compositions
HK19095A (en) Pharmaceutical compositions containing ranitidine
AU1112395A (en) Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
ZA848140B (en) New benzenesulfonyl-lactams,process for their preparation and their use as active substances of pharmaceutical compositions
CA2020346A1 (fr) Facteurs a1, a2, a3 et h de l'antibiotique ge 2270
IE41922L (en) Pharmaceutical compositions containing bischromones
IE781610L (en) Antithrombotic composition
CA2078885A1 (fr) Compositions pharmaceutiques contenant de l'amethocaine
AU589781B2 (en) New derivatives of 4-phenyl-4-oxo-2-butenoic acid, their preparation process, their use as medicaments and the compositions containing them
EP0347225A3 (fr) Compositions pharmaceutiques contenant de la primycine
AU3071289A (en) New derivatives of 1-arylsulphonyl-2-pyrrolidinone their preparation process and the new intermediates thus obtained, their use as medicaments and the compositions containing them
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
AU621677B2 (en) Stable aqueous solutions of primycin, pharmaceutical and cosmetic compositions containing these solutions and process for preparing same

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry